About Deoxyhypusine hydroxylase
Deoxyhypusine hydroxylase (DOHH) is a protein
from Homo sapiens identified by UniProt accession
Q9BU89, 302 residues long.
MolForge cross-references it against 0 known binders and
49 disease associations.
Target properties
| Protein name | Deoxyhypusine hydroxylase |
| UniProt accession | Q9BU89 |
| Gene | DOHH |
| Organism | Homo sapiens |
| Length | 302 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (4)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (49)
Diseases linked to this target (Open Targets).
- neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment · score 0.67
- complex neurodevelopmental disorder · score 0.37
- neurodegenerative disease · score 0.36
- Neurodevelopmental disorder · score 0.19
- neuronal ceroid lipofuscinosis 1 · score 0.04
- familial isolated congenital asplenia · score 0.04
- body height · score 0.04
- skin pigmentation measurement · score 0.04
- Red cell distribution width · score 0.04
- high density lipoprotein cholesterol measurement · score 0.03
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BU89-F1 | alphafold | PREDICTED | 96.06 | — |
Amino-acid sequence (302 residues)
MVTEQEVDAI GQTLVDPKQP LQARFRALFT LRGLGGPGAI AWISQAFDDD SALLKHELAY CLGQMQDARA IPMLVDVLQD TRQEPMVRHE AGEALGAIGD PEVLEILKQY SSDPVIEVAE TCQLAVRRLE WLQQHGGEPA AGPYLSVDPA PPAEERDVGR LREALLDESR PLFERYRAMF ALRNAGGEEA ALALAEGLHC GSALFRHEVG YVLGQLQHEA AVPQLAAALA RCTENPMVRH ECAEALGAIA RPACLAALQA HADDPERVVR ESCEVALDMY EHETGRAFQY ADGLEQLRGA PS
Explore Deoxyhypusine hydroxylase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets